Amundi’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101M | Buy |
2,797,471
+1,560,093
| +126% | +$56.5M | 0.03% | 412 |
|
|
2025
Q1 | $39.3M | Sell |
1,237,378
-1,316,620
| -52% | -$41.9M | 0.01% | 582 |
|
|
2024
Q4 | $66.9M | Sell |
2,553,998
-1,137,257
| -31% | -$29.8M | 0.02% | 503 |
|
|
2024
Q3 | $101M | Buy |
3,691,255
+1,627,093
| +79% | +$44.5M | 0.04% | 398 |
|
|
2024
Q2 | $53.5M | Sell |
2,064,162
-144,293
| -7% | -$3.74M | 0.02% | 506 |
|
|
2024
Q1 | $61.6M | Sell |
2,208,455
-1,484,441
| -40% | -$41.4M | 0.03% | 473 |
|
|
2023
Q4 | $105M | Buy |
3,692,896
+2,080,841
| +129% | +$59M | 0.05% | 376 |
|
|
2023
Q3 | $44.9M | Buy |
1,612,055
+239,735
| +17% | +$6.67M | 0.02% | 531 |
|
|
2023
Q2 | $42.1M | Buy |
1,372,320
+339,635
| +33% | +$10.4M | 0.02% | 546 |
|
|
2023
Q1 | $37.5M | Buy |
1,032,685
+176,317
| +21% | +$6.4M | 0.02% | 571 |
|
|
2022
Q4 | $33.7M | Buy |
856,368
+26,762
| +3% | +$1.05M | 0.02% | 585 |
|
|
2022
Q3 | $34.6M | Sell |
829,606
-106,960
| -11% | -$4.46M | 0.02% | 578 |
|
|
2022
Q2 | $40.4M | Buy |
936,566
+636,589
| +212% | +$27.5M | 0.03% | 485 |
|
|
2022
Q1 | $12.2M | Buy |
299,977
+100,254
| +50% | +$4.09M | 0.01% | 762 |
|
|
2021
Q4 | $8.03M | Sell |
199,723
-1,193,558
| -86% | -$48M | 0.01% | 898 |
|
|
2021
Q3 | $50.4M | Sell |
1,393,281
-1,434,984
| -51% | -$51.9M | 0.04% | 443 |
|
|
2021
Q2 | $116M | Buy |
+2,828,265
| New | +$116M | 0.08% | 258 |
|